These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30928701)

  • 1. Induction of humoral and cellular immune response to HBV vaccine can be up-regulated by STING ligand.
    Ito H; Kanbe A; Hara A; Ishikawa T
    Virology; 2019 May; 531():233-239. PubMed ID: 30928701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of humoral and cellular immune response to hepatitis B virus (HBV) vaccine can be upregulated by CpG oligonucleotides complexed with Dectin-1 ligand.
    Ito H; Ando T; Nakamura M; Ishida H; Kanbe A; Kobiyama K; Yamamoto T; Ishii KJ; Hara A; Seishima M; Ishikawa T
    J Viral Hepat; 2017 Feb; 24(2):155-162. PubMed ID: 27807909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
    Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
    Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X; Yang X; Li L; Liu H; Liu J
    Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mushroom lectin enhanced immunogenicity of HBV DNA vaccine in C57BL/6 and HBsAg-transgenic mice.
    Gao W; Sun Y; Chen S; Zhang J; Kang J; Wang Y; Wang H; Xia G; Liu Q; Kang Y
    Vaccine; 2013 Apr; 31(18):2273-80. PubMed ID: 23499522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model.
    Mahdavi M; Mavandadnejad F; Yazdi MH; Faghfuri E; Hashemi H; Homayouni-Oreh S; Farhoudi R; Shahverdi AR
    J Infect Public Health; 2017; 10(1):102-109. PubMed ID: 27026241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
    Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
    Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
    Leroux-Roels G; Van Belle P; Vandepapeliere P; Horsmans Y; Janssens M; Carletti I; Garçon N; Wettendorff M; Van Mechelen M
    Vaccine; 2015 Feb; 33(8):1084-91. PubMed ID: 25444781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single dose HBsAg CS-γ-PGA nanogels induce potent protective immune responses against HBV infection.
    Wang H; Han Q; Zhao H; Xu D; Zhang J
    Eur J Pharm Biopharm; 2018 Mar; 124():82-88. PubMed ID: 29247691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBV antigen and DNA loss from mouse serum is associated with novel vaccine-induced HBV surface antigen-specific cell-mediated immunity and cytokine production.
    Chuai X; Xie B; Deng Y; Zhao Y; Wang W; Gao Z; Wang W; Qiu X; Tan W
    Antiviral Res; 2019 Jan; 161():20-27. PubMed ID: 30423362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
    Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX
    Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.
    Buchmann P; Dembek C; Kuklick L; Jäger C; Tedjokusumo R; von Freyend MJ; Drebber U; Janowicz Z; Melber K; Protzer U
    Vaccine; 2013 Feb; 31(8):1197-203. PubMed ID: 23306359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse model with age-dependent immune response and immune-tolerance for HBV infection.
    Yi X; Yuan Y; Li N; Yi L; Wang C; Qi Y; Gong L; Liu G; Kong X
    Vaccine; 2018 Feb; 36(6):794-801. PubMed ID: 29306503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming tolerance in hepatitis B virus transgenic mice: a possible involvement of regulatory T cells.
    Roh S; Kim K
    Microbiol Immunol; 2003; 47(6):453-60. PubMed ID: 12906106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breaking B and T cell tolerance using cationic lipid--DNA complexes (CLDC) as a vaccine adjuvant with hepatitis B virus (HBV) surface antigen in transgenic mice expressing HBV.
    Morrey JD; Motter NE; Chang S; Fairman J
    Antiviral Res; 2011 Jun; 90(3):227-30. PubMed ID: 21545812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunizations with hepatitis B viral antigens and a TLR7/8 agonist adjuvant induce antigen-specific immune responses in HBV-transgenic mice.
    Wang Y; Chen K; Wu Z; Liu Y; Liu S; Zou Z; Chen SH; Qu C
    Int J Infect Dis; 2014 Dec; 29():31-6. PubMed ID: 25449231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C; Peng G; Jin X; Tang J; Chen Z
    Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice.
    Ito D; Ito H; Ando T; Sakai Y; Ideta T; Ishii KJ; Ishikawa T; Shimizu M
    Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36972390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmented humoral and cellular immune response of hepatitis B virus DNA vaccine by micro-needle vaccination using Flt3L as an adjuvant.
    Zhou Q; Wang F; Yang F; Wang Y; Zhang X; Sun S
    Vaccine; 2010 Feb; 28(5):1357-62. PubMed ID: 19932674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.